1.Clinical application of caudate lobe hepatocarcinoma resection
Chinese Journal of Postgraduates of Medicine 2008;31(17):27-29
Objective To discuss the feasibility of caudate lobe hepatocarcinoma resection and summarize the experience.Methods Seven hepatocarcinoma resection cases from October 2003 to October 2007 were retrospectively reviewed.Result All these 7 patients Were operated successfully.Three cases survived 12,18 and 23 months after carcinosectomy respectively.After operation,4 cases had been alive for 10,11,17 and 24 months respectively.Conclusions The caudate lobe hepatocarcinoma resection is more difficult and more risky,but it is still the best therapy for caudate lobe hepatocarcinoma.Reasonable operation and postoperative combined therapy can get the satisfied long-term effect.
2.Surgical treatment on carcinoma of ampulla by local resection
Chinese Journal of Primary Medicine and Pharmacy 2008;15(3):422-423
Objective To discuss the feasibility and curative effect of local resection on carcinoma of ampulla by duodenum.Methods 8 patients with ampulla of vater carcinoma were 1reared by local resections from January 2001 to July 2006.And one case was adenoma,the other were adenocarcinoma.Our methods of operation were the following:we cutted the vater periampullary tumor ring-shapedly far 2cm from tumor,and resected the 1.5~2.0 cmextreme of bile vessel and pancrealic duct.We rebuilded bile vessel and pancreatic duct and embedded them to duodenum.Results The 8 cases were recovered successfully,and there were on complications on them.Their average hospital days were 16 days.All of the patients were following-up,6 cases without tumor survived more than 20~68 months,and 1 case with adenoma has survived for more than 4 years.Conclusion Local resection on carcinoma of ampulla by duodenum is feasible,its wound,complications and death rate were lower.As long as the cases were suitable,parts of patients can be cured radically.
3.Current status and progress on non-surgical treatment of patients with primary liver cancer
Siyao CHE ; Longguang HE ; Qinshou CHEN ; Simin HUANG
Chinese Journal of Hepatobiliary Surgery 2016;22(6):428-432
Primary liver cancer ( PLC) , the most com-mon malignant carcinoma in the world , greatly impairs the hu-man health .Various treatments for PLC have been practiced but the therapeutic effects are still unsatisfied .Nowadays, interven-tional therapy , chemotherapy , radiotherapy , molecular targeted therapy and radiofrequency ablation are playing a key role in hepatocellular carcinoma treatment .In near future , more ad-vancements on comprehensive therapy for PLC are being expec-ted.This review aimed to describe the recent scenario and cur-rent advancement on non-surgical treatment for hepatocellular carcinoma .